| PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia Y Xie, X Shi, K Sheng, G Han, W Li, Q Zhao, B Jiang, J Feng, J Li, Y Gu Molecular medicine reports 19 (2), 783-791, 2019 | 539 | 2019 |
| CD106 identifies a subpopulation of mesenchymal stem cells with unique immunomodulatory properties ZX Yang, ZB Han, YR Ji, YW Wang, L Liang, Y Chi, SG Yang, LN Li, ... PloS one 8 (3), e59354, 2013 | 262 | 2013 |
| Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies H Yang, S Kurtenbach, Y Guo, I Lohse, MA Durante, J Li, Z Li, H Al-Ali, ... Blood, The Journal of the American Society of Hematology 131 (3), 328-341, 2018 | 176 | 2018 |
| Abnormal immunity and stem/progenitor cells in acquired aplastic anemia JP Li, CL Zheng, ZC Han Critical reviews in oncology/hematology 75 (2), 79-93, 2010 | 116 | 2010 |
| Differential gene expression profile associated with the abnormality of bone marrow mesenchymal stem cells in aplastic anemia J Li, S Yang, S Lu, H Zhao, J Feng, W Li, F Ma, Q Ren, B Liu, L Zhang, ... PLoS One 7 (11), e47764, 2012 | 92 | 2012 |
| Intravenous administration of bone marrow mesenchymal stem cells benefits experimental autoimmune myasthenia gravis mice through an immunomodulatory action J Yu, C Zheng, X Ren, J Li, M Liu, L Zhang, L Liang, W Du, Z Chao Han Scandinavian journal of immunology 72 (3), 242-249, 2010 | 67 | 2010 |
| ASXL1 interacts with the cohesin complex to maintain chromatid separation and gene expression for normal hematopoiesis Z Li, P Zhang, A Yan, Z Guo, Y Ban, J Li, S Chen, H Yang, Y He, J Li, ... Science advances 3 (1), e1601602, 2017 | 50 | 2017 |
| Interleukin‐27 as a negative regulator of human neutrophil function JP Li, H Wu, W Xing, SG Yang, SH Lu, WT Du, JX Yu, F Chen, L Zhang, ... Scandinavian journal of immunology 72 (4), 284-292, 2010 | 44 | 2010 |
| Loss of ASXL1 in the bone marrow niche dysregulates hematopoietic stem and progenitor cell fates P Zhang, Z Chen, R Li, Y Guo, H Shi, J Bai, H Yang, M Sheng, Z Li, Z Li, ... Cell discovery 4 (1), 4, 2018 | 43 | 2018 |
| Widespread microRNA degradation elements in target mRNAs can assist the encoded proteins L Li, P Sheng, T Li, CJ Fields, NM Hiers, Y Wang, J Li, CM Guardia, ... Genes & development 35 (23-24), 1595-1609, 2021 | 37 | 2021 |
| CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia S Lu, M Ge, Y Zheng, J Li, X Feng, S Feng, J Huang, Y Feng, D Yang, ... Stem Cell Research & Therapy 8, 1-14, 2017 | 37 | 2017 |
| Impaired immunomodulatory ability of bone marrow mesenchymal stem cells on CD4+ T cells in aplastic anemia J Li, S Lu, S Yang, W Xing, J Feng, W Li, Q Zhao, H Wu, M Ge, F Ma, ... Results in Immunology 2, 142-147, 2012 | 37 | 2012 |
| Interleukin‐27 enhances the production of tumour necrosis factor‐α and interferon‐γ by bone marrow T lymphocytes in aplastic anaemia J Li, Q Zhao, W Xing, J Feng, H Wu, H Li, M Ge, K Tian, X Li, J Zhou, B Liu, ... British journal of haematology 153 (6), 764-772, 2011 | 36 | 2011 |
| PRC2 inhibitors overcome glucocorticoid resistance driven by NSD2 mutation in pediatric acute lymphoblastic leukemia J Li, J Hlavka-Zhang, JH Shrimp, C Piper, D Dupéré-Richér, JS Roth, ... Cancer Discovery 12 (1), 186-203, 2022 | 29 | 2022 |
| Loss of Asxl2 leads to myeloid malignancies in mice J Li, F He, P Zhang, S Chen, H Shi, Y Sun, Y Guo, H Yang, N Man, ... Nature communications 8 (1), 15456, 2017 | 29 | 2017 |
| MYB-activated models for testing therapeutic agents in adenoid cystic carcinoma Y Jiang, R Gao, C Cao, L Forbes, J Li, S Freeberg, KM Fredenburg, ... Oral oncology 98, 147-155, 2019 | 26 | 2019 |
| MicroRNA-363 and GATA-1 are regulated by HIF-1α in K562 cells under hypoxia Y Xie, W Li, J Feng, T Wu, J Li Molecular medicine reports 14 (3), 2503-2510, 2016 | 24 | 2016 |
| Recruitment of FBXO22 for targeted degradation of NSD2 DY Nie, JR Tabor, J Li, M Kutera, J St-Germain, RP Hanley, E Wolf, ... Nature Chemical Biology 20 (12), 1597-1607, 2024 | 17 | 2024 |
| DNMT3A harboring leukemia-associated mutations directs sensitivity to DNA damage at replication forks K Venugopal, Y Feng, P Nowialis, H Xu, DE Shabashvili, CM Berntsen, ... Clinical Cancer Research 28 (4), 756-769, 2022 | 14 | 2022 |
| Decreased miR-144 expression as a non-invasive biomarker for acute myeloid leukemia patients Q Zhao, J Li, S Chen, K Shen, G Ai, X Dai, B Xie, Y Shi, S Jiang, J Feng, ... Die Pharmazie-An International Journal of Pharmaceutical Sciences 72 (4 …, 2017 | 11 | 2017 |
